Download Your Complimentary Copy of the Agenda
20 New companies including EsoBiotec, Pan Cancer T, Quell Therapeutics and Immunokey
Key sessions covering R&D all the way to commercialisation and everything in between
Data from leading in-vivo, CAR-NK, CAR-T, TCR-T, and CAR-Macrophage developers
Strategic insights to streamline regulatory approvals and discover opportunities for funding
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.